Immediate Impact

1 by Nobel laureates 3 from Science/Nature 65 standout
Sub-graph 1 of 23

Citing Papers

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week
2021 Standout
2 intermediate papers

Works of M. Versola being referenced

A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
2009
Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
M. Versola 366 176 88 99 22 453
H. Raftopoulos 229 226 46 92 18 412
Joseph Gibbons 189 173 166 101 17 477
L. Leopold 202 157 39 166 27 434
Jonathon Vallejo 291 148 46 77 27 486
George Orphanos 219 97 34 107 18 427
L. Hart 244 176 42 215 25 503
Y-H Im 285 171 44 73 22 392
Rodrigo Ruiz-Soto 182 89 45 171 19 398
Robert Alter 253 195 40 124 29 446
K. Nathan Sankar 247 155 29 112 38 462

All Works

Loading papers...

Rankless by CCL
2026